Cargando…

735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016

BACKGROUND: In 2014, the American Academy of Pediatrics recommended against the use of respiratory syncytial virus (RSV) immunoprophylaxis in infants 29–34 weeks gestational age (wGA) at birth without chronic lung disease/bronchopulmonary dysplasia (CLD/BPD) or congenital heart disease (CHD). To inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldstein, Mitchell, Krilov, Leonard R, Fergie, Jaime, Ambrose, Christopher S, Wade, Sally, Kong, Amanda, Brannman, Lance
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253181/ http://dx.doi.org/10.1093/ofid/ofy210.742

Ejemplares similares

740. Impact of the 2014 American Academy of Pediatrics Guidance on Respiratory Syncytial Virus Hospitalization Rates for Preterm Infants <29 Weeks Gestational Age at Birth: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation
por: Goldstein, Mitchell, et al.
Publicado: (2021)

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
por: Fergie, Jaime, et al.
Publicado: (2020)

743. Severity and Costs of Respiratory Syncytial Virus and Bronchiolitis Hospitalization in Commercially Insured Preterm and Term Infants Before and After the 2014 American Academy of Pediatrics Guidance Change on Immunoprophylaxis
por: Krilov, Leonard R, et al.
Publicado: (2018)

The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States
por: Kong, Amanda M., et al.
Publicado: (2018)

Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States
por: Goldstein, Mitchell, et al.
Publicado: (2021)

Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis
por: Ambrose, Christopher S., et al.
Publicado: (2014)

Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age
por: Franklin, Jeremy A., et al.
Publicado: (2016)

Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation
por: Simões, Eric A. F., et al.
Publicado: (2016)

Correction: Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation
por: Simões, Eric A. F., et al.
Publicado: (2016)

Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics
por: Krilov, Leonard R., et al.
Publicado: (2020)

The effects of betamethasone on clinical outcome of the late preterm neonates born between 34 and 36 weeks of gestation
por: Arimi, Yas, et al.
Publicado: (2021)

Neurodevelopmental Outcomes at 18 Months of Corrected Age for Late Preterm Infants Born at 34 and 35 Gestational Weeks
por: Nakasone, Ruka, et al.
Publicado: (2021)

National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015
por: Krilov, Leonard R, et al.
Publicado: (2017)

2638. Respiratory Syncitial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among 29–34 Weeks Gestational Age (wGA) Preterm Infants Before and After the 2014 American Academy of Pediatrics (AAP) Immunoprophylaxis Policy Change Using the Children’s Hospital Association’s Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2019)

749. Healthcare Utilization After Hospitalization for Respiratory Syncytial Virus or Unspecified Bronchiolitis in the First Year of Life
por: Ledbetter, Joel, et al.
Publicado: (2018)

Thyroid dysfunction in preterm infants born before 32 gestational weeks
por: Kim, Hye-Rim, et al.
Publicado: (2019)

Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
por: Resch, B., et al.
Publicado: (2017)

Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort study
por: Pierrat, Véronique, et al.
Publicado: (2017)

Bronchopulmonary Dysplasia in Preterm Infants Born at Less Than 32 Weeks Gestation
por: Xu, Yan-Ping
Publicado: (2016)

Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study
por: Chevallier, Marie, et al.
Publicado: (2019)

Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation
por: Wu, Yunjiao, et al.
Publicado: (2023)

Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea
por: Lee, Jang Hoon, et al.
Publicado: (2015)

Outpatient versus inpatient care for preterm premature rupture of membranes before 34 weeks of gestation
por: Bouchghoul, Hanane, et al.
Publicado: (2019)

Midterm Neuromotor Development Results of Preterm Babies less than 34 Weeks Gestational Age
por: Bulbul, Ali, et al.
Publicado: (2020)

Perinatal outcomes of twin pregnancies with preterm premature rupture of the membranes at 24–34 weeks’ gestation
por: Zhou, Shuwei, et al.
Publicado: (2021)

Long‐term renal follow up of preterm neonates born before 35 weeks of gestation
por: Horie, Akiyoshi, et al.
Publicado: (2019)

Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change
por: Krilov, Leonard R., et al.
Publicado: (2021)

Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
por: Anderson, Evan J., et al.
Publicado: (2017)

Pattern of intracranial findings detected on magnetic resonance imaging in surviving infants born before 29 weeks of gestation
por: Petrova, Anna, et al.
Publicado: (2019)

Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study
por: GOUYON, J.-B., et al.
Publicado: (2013)

Histological chorioamnionitis is associated with an increased risk of wheezing in preterm children less than 34 gestational weeks
por: Wang, Xiaoli, et al.
Publicado: (2021)

Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data
por: Kong, Amanda M., et al.
Publicado: (2021)

Born at 27 weeks of gestation with classical PKU: challenges of dietetic management in a very preterm infant
por: Ballhausen, Diana, et al.
Publicado: (2011)

Complementary feeding at 4 versus 6 months of age for preterm infants born at less than 34 weeks of gestation: a randomised, open-label, multicentre trial
por: Gupta, Shuchita, et al.
Publicado: (2017)

PT735. Multisensory integration of social interaction
por: Bae, Dahye, et al.
Publicado: (2016)

A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age
por: Keary, Ian P., et al.
Publicado: (2023)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umq81u84573ir0phjk5pbm0p6i